Anthony Green, M.D., Ph.D., Cambridge Institute for Medical research, Myeloproliferative Neoplasms

Dr. Green’s work is aimed at understanding at the genomic scale of how patients with myeloproliferative neoplasms (MPNs) respond to therapy. Research has shown that defects in one gene, JAK2, are present in most, but not all patients with MPNs, diseases that affect approximately 200,000 people in the United States. This and other molecular discoveries will help develop new approaches to the diagnosis and treatment of these disorders.

Dr. Green leads an LLS Specialized Center of Research grant.

Learn more about LLS funded research at http://www.lls.org/aboutlls/researchsuccesses/